EnBio Holdings, Inc

TSE:6092 Stock Report

Market Cap: JP¥4.7b

EnBio Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 6092?
Owner TypeNumber of SharesOwnership Percentage
Private Companies60,0000.742%
Institutions581,0747.19%
Individual Insiders1,589,50019.7%
Public Companies2,780,00034.4%
General Public3,071,13638%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 23 shareholders own 62% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
34.4%
CRE, Inc.
2,780,000JP¥1.6b0%no data
6.13%
Minoru Nishimura
495,500JP¥287.4m0%no data
5.35%
Yoshikazu Nakamura
432,000JP¥250.6m0%no data
2.47%
Koichiro Hirata
200,000JP¥116.0m0%no data
2%
Masaaki Nemoto
161,500JP¥93.7m58.6%no data
1.35%
SBI Holdings Inc., Asset Management Arm
108,989JP¥63.2m0%0.02%
1.11%
SBI Okasan Asset Management Co., Ltd.
90,100JP¥52.3m0%0.01%
1.11%
Mitsubishi UFJ Trust and Banking Corporation, Asset Management Arm
90,000JP¥52.2m0%no data
1%
Ueda Yagi Tanshi Co. Ltd., Asset Management Arm
81,100JP¥47.0m0%0.07%
1%
Tetsushi Nakama
80,500JP¥46.7m0%no data
0.96%
Rakuten Investment Management, Inc.
77,500JP¥45.0m0%0.02%
0.93%
Nomura Holdings Inc, Securities & Investment Arm
74,785JP¥43.4m0%no data
0.74%
Sakura General Surface Limited
60,000JP¥34.8m0%no data
0.73%
The Tokyo Tanshi Co., Ltd., Asset Management Arm
58,600JP¥34.0m-6.09%0.16%
0.72%
Kento Arakawa
58,000JP¥33.6m0%no data
0.68%
Toyoko Osawa
55,000JP¥31.9m0%no data
0.63%
Hirotaka Shimizu
51,300JP¥29.8m0%no data
0.19%
Toshihito Yamamoto
15,500JP¥9.0m0%no data
0.19%
Ichiro Namekawa
15,000JP¥8.7m0%no data
0.17%
Yukinobu Yokomizo
14,100JP¥8.2m0%no data
0.12%
Takahiro Hoshino
10,000JP¥5.8m0%no data
0.012%
Yuki Odake
1,000JP¥579.8k0%no data
0.0012%
Tadahide Kameyama
100JP¥58.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 13:12
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

EnBio Holdings, Inc is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yoko MizoguchiIchiyoshi Research Institute Inc.
Eiji TomaruMizuho Securities Co., Ltd.